- MDBZ
- N-Benzyl-3,4-methylenedioxyamphetamine
- N-Benzyl-MDA
- 3,4-Methylenedioxy-N-benzylamphetamine
- 1-(2H-1,3-Benzodioxol-5-yl)-N-benzylpropan-2-amine
- 1-(1,3-Benzodioxol-5-yl)-N-benzylpropan-2-amine
Braun, U; Shulgin, AT; Braun, G. Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine) J. Pharm. Sci., 1 Jan 1980, 69 (2), 192–195. 513 kB. https://doi.org/10.1002/jps.2600690220 #IIq
Nieddu, M; Burrai, L; Pirisi, MA; Carta, A; Briguglio, I; Dessi, G; Boatto, G. Validated liquid chromatography-mass spectrometry method for the quantitation of N-substituted derivatives of 3,4-methylenedioxyamphetamine in rat urine Forensic Toxicol., 1 Jul 2013, 31 (2), 204–211. 527 kB. https://doi.org/10.1007/s11419-013-0178-5 LC,NMR
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.